These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 7899253

  • 1. Cerebral vascular smooth muscle potassium channels and their possible role in the management of vasospasm.
    Zhang H, Cook D.
    Pharmacol Toxicol; 1994 Dec; 75(6):327-36. PubMed ID: 7899253
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS.
    J Cardiovasc Pharmacol; 1994 Dec; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [Abstract] [Full Text] [Related]

  • 3. Potassium channel activator drugs: mechanism of action, pharmacological properties, and therapeutic potential.
    Longman SD, Hamilton TC.
    Med Res Rev; 1992 Mar; 12(2):73-148. PubMed ID: 1535674
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery.
    Ksoll E, Parsons AA, Mackert JR, Schilling L, Wahl M.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):377-83. PubMed ID: 1830131
    [Abstract] [Full Text] [Related]

  • 8. Effects of K+ channel agonists cromakalim and pinacidil on rat basilar artery smooth muscle cells are mediated by Ca(++)-activated K+ channels.
    Stockbridge N, Zhang H, Weir B.
    Biochem Biophys Res Commun; 1991 Nov 27; 181(1):172-8. PubMed ID: 1958186
    [Abstract] [Full Text] [Related]

  • 9. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
    Kamijo T, Tomaru T, Miwa A, Nakamura F, Kido H, Sugimoto T, Uchida Y.
    Nihon Yakurigaku Zasshi; 1992 Oct 27; 100(4):317-27. PubMed ID: 1446882
    [Abstract] [Full Text] [Related]

  • 10. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA, Stork AP.
    Br J Pharmacol; 1992 Jan 27; 105(1):51-8. PubMed ID: 1534504
    [Abstract] [Full Text] [Related]

  • 11. [Advance in pharmacology of potassium channels in cardiovascular system and their clinical use].
    Wu Y, Fang D.
    Zhonghua Yi Xue Za Zhi; 1992 Mar 27; 72(3):180-3. PubMed ID: 1319810
    [No Abstract] [Full Text] [Related]

  • 12. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
    Satoh H.
    J Cardiovasc Pharmacol; 1993 Dec 27; 22(6):863-8. PubMed ID: 7509906
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative electrophysiological and mechanical actions of ATP-sensitive potassium channel openers in canine Purkinje fibers.
    Satoh H.
    Gen Pharmacol; 1993 May 27; 24(3):565-75. PubMed ID: 8365637
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle.
    Satoh E, Yanagisawa T, Taira N.
    Jpn J Pharmacol; 1990 Oct 27; 54(2):133-41. PubMed ID: 2150209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.